Finch Therapeutics Group, Inc. (FNCH)
OTCMKTS
· Delayed Price · Currency is USD
13.40
-0.20 (-1.47%)
Jun 18, 2025, 11:52 AM EDT
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $21.57 million as of June 18, 2025. Its market cap has increased by 478.97% in one year.
Market Cap
21.57M
Enterprise Value
34.52M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$13.40
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 21.57M, a decrease of -97.85%. That is a compound annual growth rate of -59.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 21.57M | 18.87% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.62B |
| Veradigm | 755.74M |
| Elite Pharmaceuticals | 715.74M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 637.25M |
| American Oncology Network | 414.48M |
| Glass House Brands | 405.91M |
| CytoDyn | 398.21M |